ANIP ANI PHARMACEUTICALS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 10 analyst firms say about ANI PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
9 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8053
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8045
Recent analyst activity · last 90 days
Our tracked history has 6 reports on ANIP from 6 analyst firms in the last 90 days (10 firms in the past year).
Comparing each firm's latest target with its previous one: 2 lowered it and 3 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Canaccord Genuity lowered its target from $91.00 (set 17 Jul 2026) to $90.00 on 10 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Glen Santangelo | Buy | 5 Aug 2026 | 100.00 USD |
| Canaccord Genuity | Gary Nachman | Hold | 10 Aug 2026 | 90.00 USD |
| Guggenheim | Vamil Divan | Buy | 10 Aug 2026 | 119.00 USD |
| H.C. Wainwright | Brandon Folkes | Buy | 11 Aug 2026 | 121.00 USD |
| Jefferies | Dennis Ding | Buy | 1 Jul 2026 | 120.00 USD |
| Leerink Partners | Thomas J Smith | Buy | 9 Sep 2026 | 104.00 USD |
| Oppenheimer | Les Sulewski | Hold | 23 Sep 2026 | 85.00 USD |
| Piper Sandler | David Amsellem | Buy | 7 Aug 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 11 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 14 May 2026 | 76.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:59 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.